Acciones Callitas Health Inc. Canadian Securities Exchange
Acciones
LILY
CA13125C1068
Biotecnología e investigación médica
Ventas 2018 | 0,75 1,02 0,69 | Ventas 2019 | 0,71 0,96 0,65 | Capitalización | 3,53 M 4,8 M 3,24 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -5 M -6,8 M -4,6 M | Resultado Neto 2019 | -1 M -1,36 M -919 mil | VE / Ventas 2018 | 4.852.616 x |
Deuda neta 2018 | 319 mil 434 mil 293 mil | Deuda neta 2019 | 848 mil 1,15 M 779 mil | VE / Ventas 2019 | 6.168.166 x |
P/E ratio 2018 |
-0,6
x | P/E ratio 2019 |
-1,97
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 72,04 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 03/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/12/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,41 % | 49,18 mil M | |
+0,67 % | 42,11 mil M | |
+50,47 % | 40,37 mil M | |
-5,26 % | 28,85 mil M | |
+13,68 % | 26,09 mil M | |
-22,74 % | 18,71 mil M | |
+8,22 % | 13,26 mil M | |
+32,78 % | 12,32 mil M | |
-1,37 % | 11,99 mil M |